rituximab,cyclophosphamide
biogen,roche
[]
dr. maher - similar improvement in cyc and rtx. no superiority in effectiveness. however fewer adverse events in rtx arm. #plenary #pulmonary #myositis #acr22 
Rheumatologist | @ACRheum MarCom Chair | @TexMed Delegate | TexMed Leadership College????? | ???? | Views = Mine | Re-tweet ? endorsement